ArticleFrontiers in oncology2026

Real-world effectiveness and safety of carfilzomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma: a retrospective analysis from China.

Wei Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.